Abstract
Purpose
Stage at diagnosis is an important prognostic factor for the majority of cancers; it may be an indicator for quality of access to health care and is usually correlated with socioeconomic status (SES) and ethnicity/race. We aimed to investigate the association between stage of cancer at diagnosis with neighborhood of residence (as proxy for SES) and ethnicity/race, while controlling for each other, in selected areas of New York City (NYC).
Methods
The cancer summary data (1999–2008) were provided by the New York State Cancer Registry. Multinomial logistic regression models were applied to calculate risk estimates for being diagnosed with late- or unknown-stage (versus early-stage) cancers in two low-SES and two high-SES neighborhoods of NYC and among several ethnic/racial groups for all cancers combined and cancers of the female breast, lung, colorectum, and prostate, with additional adjustments for sex (for all cancers combined), age, and year of diagnosis.
Results
A total of 34,981 cancer cases were included in this study. There were significant and independent ethnic/racial and neighborhood disparities in stage of cancer at diagnosis of most of the cancers studied. The effect of ethnicity/race on the disparity appeared stronger than the effect of neighborhood. There was an overall decreasing trend in the proportion of late-stage cancers, particularly for colorectal cancer, and to a greater extent in the proportion of cancers without staging information.
Conclusions
In this population, ethnicity/race seems to be a stronger predictor for late stage at diagnosis than SES, stressing the need for ethnicity/race-oriented programs for cancer screening and improved access to care.
Similar content being viewed by others
References
Abraham J, Gulley JL, Allegra CJ (2010) The Bethesda handbook of clinical oncology. Lippincott Williams & Wilkins, Philadelphia
Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A, Krischer JP (1999) Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91:1409–1415
Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Uy GL, Toral JA, Benavides D, Brenner H (2009) Ethnicity and health care in cervical cancer survival: comparisons between a Filipino resident population, Filipino-Americans, and Caucasians. Cancer Epidemiol Biomarkers Prev 18:2228–2234
Halpern MT, Pavluck AL, Ko CY, Ward EM (2009) Factors associated with colon cancer stage at diagnosis. Dig Dis Sci 54:2680–2693
Slatore CG, Au DH, Gould MK (2010) An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med 182:1195–1205
Woods LM, Rachet B, Coleman MP (2006) Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 17:5–19
Hashibe M, Siwakoti B, Wei M, Thakur BK, Pun CB, Shrestha BM, Burningham Z, Lee YC, Sapkota A (2011) Socioeconomic status and lung cancer risk in Nepal. Asian Pac J Cancer Prev 12:1083–1088
Cueto CV, Szeja S, Wertheim BC, Ong ES, Tsikitis VL (2011) Disparities in treatment and survival of White and Native American patients with colorectal cancer: a SEER analysis. J Am Coll Surg 213:469–474
Sun M, Abdollah F, Liberman D, Abdo A, Thuret R, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI (2011) Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer 117:4277–4285
Aarts MJ, Voogd AC, Duijm LE, Coebergh JW, Louwman WJ (2011) Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands–associations with stage at diagnosis and survival. Breast Cancer Res Treat 128:517–525
Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, Goodman MT, Lynch CF, Schwartz SM, Chen VW, Bernstein L, Gomez SL, Graff JJ, Lin CC, Johnson NJ, Edwards BK (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 20:417–435
Menashe I, Anderson WF, Jatoi I, Rosenberg PS (2009) Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst 101:993–1000
Echeverria SE, Borrell LN, Brown D, Rhoads G (2009) A local area analysis of racial, ethnic, and neighborhood disparities in breast cancer staging. Cancer Epidemiol Biomarkers Prev 18:3024–3029
Keegan TH, Quach T, Shema S, Glaser SL, Gomez SL (2010) The influence of nativity and neighborhoods on breast cancer stage at diagnosis and survival among California Hispanic women. BMC Cancer 10:603
McCord C, Freeman HP (1990) Excess mortality in Harlem. N Engl J Med 322:173–177
Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W (1991) Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health 81:646–649
Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J (1995) Impact of access and social context on breast cancer stage at diagnosis. J Health Care Poor Underserved 6:342–351
Kanna B, Narang TK, Atwal T, Paul D, Azeez S (2009) Ethnic disparity in mortality after diagnosis of colorectal cancer among inner city minority New Yorkers. Cancer 115:5550–5555
McCarthy AM, Dumanovsky T, Visvanathan K, Kahn AR, Schymura MJ (2010) Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995–2006. Cancer Causes Control 21:1645–1655
Ragin CC, Langevin SM, Marzouk M, Grandis J, Taioli E (2011) Determinants of head and neck cancer survival by race. Head Neck 33:1092–1098
Wich LG, Ma MW, Price LS, Sidash S, Berman RS, Pavlick AC, Miller G, Sarpel U, Goldberg JD, Osman I (2011) Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities. J Community Health 36:461–468
Bergamo C, Lin JJ, Smith C, Lurslurchachai L, Halm EA, Powell CA, Berman A, Schicchi JS, Keller SM, Leventhal H, Wisnivesky JP (2013) Evaluating beliefs associated with late-stage lung cancer presentation in minorities. J Thorac Oncol 8:12–18
New York State Cancer Registry. Colorectal cancer incidence and mortality by year, New York City, 1976–2008. http://www.health.ny.gov/statistics/cancer/registry/table 2/tb2colorectalnyc.htm. 2011
Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA (2010) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544–573
Naishadham D, Lansdorp-Vogelaar I, Siegel R, Cokkinides V, Jemal A (2011) State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev 20:1296–1302
Soneji S, Iyer SS, Armstrong K, Asch DA (2010) Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. Am J Public Health 100:1912–1916
Le H, Ziogas A, Lipkin SM, Zell JA (2008) Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev 17:1950–1962
Alexander D, Jhala N, Chatla C, Steinhauer J, Funkhouser E, Coffey CS, Grizzle WE, Manne U (2005) High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer 103:2163–2170
Advani AS, Atkeson B, Brown CL, Peterson BL, Fish L, Johnson JL, Gockerman JP, Gautier M (2003) Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 97:1499–1506
Lawsin C, DuHamel K, Weiss A, Rakowski W, Jandorf L (2007) Colorectal cancer screening among low-income African Americans in East Harlem: a theoretical approach to understanding barriers and promoters to screening. J Urban Health 84:32–44
Diaz JA, Roberts MB, Goldman RE, Weitzen S, Eaton CB (2008) Effect of language on colorectal cancer screening among Latinos and non-Latinos. Cancer Epidemiol Biomarkers Prev 17:2169–2173
Shao YH, Demissie K, Shih W, Mehta AR, Stein MN, Roberts CB, Dipaola RS, Lu-Yao GL (2009) Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 101:1280–1283
Carpenter WR, Howard DL, Taylor YJ, Ross LE, Wobker SE, Godley PA (2010) Racial differences in PSA screening interval and stage at diagnosis. Cancer Causes Control 21:1071–1080
Lawton CA, Hunt D, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky TM, Sandler H (2011) Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98–05). Int J Radiat Oncol Biol Phys 81:1–7
Donnelly BJ, Saliken JC, Brasher PM, Ernst SD, Rewcastle JC, Lau H, Robinson J, Trpkov K (2010) A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer 116:323–330
Kapoor DA, Zimberg SH, Ohrin LM, Underwood W III, Olsson CA (2011) Utilization trends in prostate cancer therapy. J Urol 186:860–864
Perlroth DJ, Goldman DP, Garber AM (2010) The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography 47(Suppl):S173–S190
Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomarkers Prev 18:121–131
Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168–183
Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86:705–712
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502
Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109:1721–1728
Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS (1998) Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 279:1801–1807
Flynn PM, Betancourt H, Ormseth SR (2011) Culture, emotion, and cancer screening: an integrative framework for investigating health behavior. Ann Behav Med 42:79–90
Ward EM, Fedewa SA, Cokkinides V, Virgo K (2010) The association of insurance and stage at diagnosis among patients aged 55–74 years in the national cancer database. Cancer J 16:614–621
Rauscher GH, Allgood KL, Whitman S, Conant E (2011) Unequal distribution of screening mammography services by race/ethnicity and health insurance. J Womens Health (Larchmt) 21:154–160
Rauscher GH, Ferrans CE, Kaiser K, Campbell RT, Calhoun EE, Warnecke RB (2010) Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients. Cancer Epidemiol Biomarkers Prev 19:640–647
Young RF, Schwartz K, Booza J (2011) Medical barriers to mammography screening of African American women in a high cancer mortality area: implications for cancer educators and health providers. J Cancer Educ 26:262–269
Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, Dignan M, Barlow WE, Beasley CM, Kerlikowske K (2006) Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144:541–553
Kaiser K, Rauscher GH, Jacobs EA, Strenski TA, Ferrans CE, Warnecke RB (2011) The import of trust in regular providers to trust in cancer physicians among white, African American, and Hispanic breast cancer patients. J Gen Intern Med 26:51–57
Goldberg SW, Mulshine JL, Hagstrom D, Pyenson BS (2010) An actuarial approach to comparing early stage and late stage lung cancer mortality and survival. Popul Health Manag 13:33–46
Gorin SS, Heck JE (2005) Cancer screening among Latino subgroups in the United States. Prev Med 40:515–526
Shelton RC, Jandorf L, King S, Thelemaque L, Erwin DO (2012) Cervical cancer screening among immigrant Hispanics: an analysis by country of origin. J Immigr Minor Health 14:715–720
Garbers S, Chiasson MA (2006) Breast cancer screening and health behaviors among African American and Caribbean Women in New York City. J Health Care Poor Underserved 17:37–46
Mehrotra N, Gaur S, Petrova A (2012) Health care practices of the foreign born Asian Indians in the United States. A community based survey. J Community Health 37:328–334
Odedina FT, Dagne G, LaRose-Pierre M, Scrivens J, Emanuel F, Adams A, Pressey S, Odedina O (2011) Within-group differences between native-born and foreign-born Black men on prostate cancer risk reduction and early detection practices. J Immigr Minor Health 13:996–1004
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Islami, F., Kahn, A.R., Bickell, N.A. et al. Disentangling the effects of race/ethnicity and socioeconomic status of neighborhood in cancer stage distribution in New York City. Cancer Causes Control 24, 1069–1078 (2013). https://doi.org/10.1007/s10552-013-0184-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-013-0184-2